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Efferent Vagal Nerve Stimulation Protects Heart Against
Ischemia-Induced Arrhythmias by Preserving
Connexin43 Protein
Motonori Ando, PhD; Rajesh G. Katare, MD; Yoshihiko Kakinuma, MD; Dongmei Zhang, MD;
Fumiyasu Yamasaki, MD; Kazuyo Muramoto, PhD; Takayuki Sato, MD
Background—Myocardial ischemia (MI) leads to derangements in cellular electrical stability and the generation of lethal
arrhythmias. Vagal nerve stimulation has been postulated to contribute to the antifibrillatory effect. Here, we suggest
a novel mechanism for the antiarrhythmogenic properties of vagal stimulation during acute MI.
Methods and Results—Under anesthesia, Wistar rats underwent 30 minutes of left coronary artery (LCA) ligation with
vagal stimulation (MI-VS group, n11) and with sham stimulation (MI-SS group, n12). Eight of the 12 rats in the
MI-SS group had ventricular tachyarrhythmia (VT) during 30-minute LCA ligation; on the other hand, VT occurred in
only 1 of the 11 rats in the MI-VS group (67% versus 9%, respectively). Atropine administration abolished the
antiarrhythmogenic effect of vagal stimulation. Immunoblotting revealed that the MI-SS group showed a marked
reduction in the amount of phosphorylated connexin43 (Cx43), whereas the MI-VS group showed only a slight reduction
compared with the sham operation and sham stimulation group (3720% versus 7918%). Immunohistochemistry
confirmed that the MI-induced loss of Cx43 from intercellular junctions was prevented by vagal stimulation. In addition,
studies with rat primary-cultured cardiomyocytes demonstrated that acetylcholine effectively prevented the hypoxia-
induced loss of phosphorylated Cx43 and ameliorated the loss of cell-to-cell communication as determined by Lucifer
Yellow dye transfer assay, which supports the in vivo results.
Conclusions—Vagal nerve stimulation exerts antiarrhythmogenic effects accompanied by prevention of the loss of
phosphorylated Cx43 during acute MI and thus plays a critical role in improving ischemia-induced electrical instability.
(Circulation. 2005;112:164-170.)
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Acute myocardial ischemia results in a dramatic reductionof tissue pH, an increase in interstitial potassium levels,
an increase in intracellular calcium concentration, and neu-
rohumoral changes, all of which contribute to the develop-
ment of electrical instability that leads to life-threatening
cardiac arrhythmias.1,2 In particular, cell-to-cell electrical
uncoupling of ventricular myocytes plays an important role in
arrhythmogenesis during acute and chronic ischemic heart
disease.3–6
Gap-junction channels, composed of highly homologous
proteins known as connexins in vertebrate species, have been
implicated in the electrical coupling of excitable tissues, such
as cardiac muscles. There are essentially 2 subtypes of
connexins (Cx), Cx40 and Cx43, in the adult heart muscle.
Cx43 is predominantly expressed in ventricular tissue,
whereas Cx40 is mainly found in atrial tissue and in the
conduction system.7 The protein content of ventricular Cx43
is remarkably reduced in ischemia8,9 and heart failure.10,11
Gene-targeting studies demonstrate that reduced expression
of Cx43 increases the incidence of ventricular
tachyarrhythmias12 and causes a significant reduction in
conduction velocity in mice during acute myocardial ische-
mia.13 These results suggest that the dysfunction of Cx43 in
cardiomyocytes could be one of the components of the
substrate that promotes lethal ventricular tachyarrhythmias.
With regard to life-threatening arrhythmias in acute ische-
mia, the effect of vagal nerve stimulation (VS) has been
reported to prevent ventricular fibrillation in dogs.14 Re-
cently, VS therapy markedly improved long-term survival in
an animal model of chronic heart failure after myocardial
infarction,15 and earlier studies have demonstrated that ven-
tricular arrhythmia is one of the major causes of death in
chronic heart failure conditions.16 However, the mechanisms
of VS on myocardial infarction remain unknown. With these
in mind, we hypothesized that VS would exert an antiarrhyth-
mogenic effect even in acute myocardial ischemia by target-
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ing the gap junctions. Therefore, in the present study, using
both an in vivo acute ischemia model in rats and in vitro
primary cultured cardiomyocytes from neonatal rats, we
examined the effects of VS on arrhythmogenesis during acute
myocardial ischemia.
Methods
The care and use of animals were in strict accordance with the
guiding principles of the Physiological Society of Japan.
In Vivo Arrhythmia Study
Male Wistar rats (SLC, Japan) weighing 270 to 300 g were assigned
to 6 groups receiving the following treatments: sham-operated rats
treated with sham stimulation (SO-SS, n6), sham-operated rats
treated with vagal stimulation (SO-VS, n5), myocardial ischemia
rats with sham stimulation (MI-SS, n12), myocardial ischemia rats
with vagal stimulation (MI-VS, n11), myocardial ischemia rats
with both vagal stimulation and atropine administration (MI-VS-Atr,
n6), and myocardial ischemia rats preconditioned by vagal stimu-
lation (pcVS-MI, n9).
Acute Ischemia Model
After induction of anesthesia, the rat was ventilated artificially with
a volume-controlled rodent respirator (model 683, Harvard Appara-
tus) at 80 strokes per minute. Anesthesia was maintained through the
use of 1.2% halothane during surgical procedures and 0.6% halo-
thane during data recording. Left ventricular MI was induced by 30
minutes of left coronary artery (LCA) ligation. In sham-operated
rats, we loosely tied a suture around the LCA without arterial
occlusion. For measurement of arterial pressure, a polyethylene
tubing (PE-10, Becton Dickinson) that was filled with saline and
connected to a fluid-filled transducer (DX-300, Viggo-Spectramed)
was cannulated into the right femoral artery. Experimental solutions
were infused through another polyethylene tubing, which was
cannulated into the right femoral vein. Atropine sulfate (1 mg/kg)
(Sigma) was administered as vagal efferent muscarinic blockade. For
the prevention of dehydration during experiments,17 physiological
saline was continuously infused at a rate of 5 mL · kg1 · h1 with a
syringe pump (CFV-3200; Nihon Kohden).
Vagal Nerve Stimulation
The right vagal nerve was identified, isolated, and cut in the neck
region. Only the distal end of the vagal nerve was placed on a pair
of platinum wires and was used for stimulation to exclude the effects
of vagal afferent. The electrode was connected to an isolated
constant voltage stimulator (SS-202J and SEN-7203, Nihon
Kohden). The vagal nerve was stimulated with electrical rectangular
pulses of 0.1-ms duration at 10 Hz during LCA ligation. The
electrical voltage of pulses was optimized in each rat to obtain a 10%
reduction in heart rate before LCA ligation. The actual electrical
voltage was in the range of 2 to 6 V. VS was started at 1 minute
before LCA ligation and continued for 30 minutes after LCA
ligation. A run of first spontaneous ventricular tachyarrhythmia (VT)
was defined as 10 or more beats with a cycle length 100 ms.
To exclude vagally induced bradycardiac effects during MI and to
investigate whether or not a heart preconditioned by VS (pcVS) was
insusceptible to ischemia-induced VT, we also examined the effect
of 10-minute VS only before LCA ligation. After a 5-minute
stabilization period for the recovery of heart rate, the rat was
subjected to 30-minute LCA ligation.
Risk Area Assessment
To confirm the ischemic area induced by LCA ligation, 2 mL of 2%
Evans blue dye was injected via the femoral vein at the end of 30
minutes of coronary artery ligation. The area at risk was determined
by negative staining with Evans blue. Area measurements were
determined with Image-Pro version 4.0 (Media Cybernetics).
Excised Heart Study
We conducted this protocol separately from the in vivo arrhythmia
study because the experimental preparation of Evans blue dye
injection for risk area assessment did not allow us to perform
immunoblotting and immunohistochemical assay of excised hearts.
For each group, we prepared and analyzed 5 hearts.
Protein Preparation and Immunoblotting
Pulverized frozen left ventricle samples were suspended in 40 vol of
ice-cold 10% trichloroacetic acid and homogenized with a tissue
homogenizer (2 bursts, 30 seconds each).18 Homogenates were
centrifuged at 10 000g for 10 minutes. Supernatants were discarded,
and the remaining pellets were resuspended in sampling solution (9
mol/L urea, 0.065 mol/L dithiothreitol, 2% Triton X-100) and
sonicated. After addition of 0.37 mol/L lithium dodecylsulfate, the
protein-containing solution was neutralized by 1 mol/L Tris solution,
and sonicated again. For immunoblot analysis, proteins separated by
SDS-PAGE with 15% polyacrylamide gels were transferred electro-
phoretically to polyvinylidene difluoride sheets (Millipore). After 1
hour of blocking in the 4% skimmed milk solution, the membrane
was incubated overnight with anti-Cx43 antibody (71-0700, Zymed)
diluted 1:1000. Blots were then incubated for 1 hour with horserad-
ish peroxidase–conjugated goat anti-rabbit IgG, developed with an
ECL chemiluminescence reagent (Amersham), and exposed to a
medical x-ray film. Equal protein content in all the samples was
confirmed by Coomassie brilliant blue staining.
Immunohistochemistry and Confocal Microscopy
Transmural blocks of left ventricular myocardium from selected
hearts were immersed in a fixative containing 4% paraformaldehyde
and 0.1 mol/L phosphate buffer (pH 7.4), embedded in paraffin, and
sectioned at a thickness of 4 m. Sections were deparaffinized,
placed in citrate buffer, and boiled in a microwave oven for 10
minutes to enhance specific immunostaining. The sections were then
incubated overnight with anti-Cx43 antibody diluted 1:100 and then
incubated for 2 hours in Alexa546-conjugated goat anti-rabbit IgG
(Molecular Probes) diluted 1:100. Fluorescence of Alexa546 was
observed with a confocal laser scanning microscope system (FV300,
Olympus). Reconstructed projection images were obtained from
serial optical sections recorded at an interval of 0.5 m.
Primary Culture Study
We used neonatal rat primary cultured cardiomyocytes to investigate
the direct action of acetylcholine (ACh), a neurotransmitter released
by VS, on phosphorylated Cx43. Hearts were excised from 1- to
2-day-old neonatal Wistar rats and digested with 0.03% type IV
collagenase (Sigma) and 0.03% trypsin (Invitrogen). After digestion,
cardiomyocytes were washed repeatedly in serum containing culture
medium and were preplated for 90 minutes in the noncoated culture
dish in the presence of DMEM medium (Sigma) with 10% FBS to
remove the contaminating noncardiomyocytes. Next, cardiomyo-
cytes were plated and cultured in gelatin-coated culture dishes in
DMEM medium with 10% FBS. New medium was replaced every
day, and all experiments were performed after 4 days of culture.
Hypoxia and Immunoblotting
For hypoxia experiments, cardiomyocytes in serum-deficient
DMEM were transferred into an airtight incubator and maintained at
a humidified hypoxic atmosphere of 2% O2 with nitrogen and 5%
CO2 for 30 minutes. Cells were treated either with ACh (0.5 mmol/L)
alone or with both ACh and atropine (0.1 mmol/L) 10 minutes before
the cells were subjected to hypoxia. After 30 minutes, the treated
cells were sampled for immunoblotting.
Dye Transfer Assay
To assess the effect of ACh on cell-to-cell communication, we
monitored dye transfer in primary cultured cardiomyocytes with
Lucifer Yellow CH (LY; lithium salt, Molecular Probes). Cells in the
culture medium were viewed on a Zeiss microscope equipped with
fluorescence illumination and FITC filters. The emitted fluorescent
light was projected onto a CCD camera system (C4742-98-24ER,
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Hamamatsu Photonics). LY was injected electrophoretically via a
conventional intracellular microelectrode made from borosilicate
glass capillaries. The outer diameter of microelectrodes was 0.15 to
0.25 m, and the tip resistance of these electrodes filled with 3% LY
was 0.6 to 1.4 G. An inward square-pulse current (20 to 40 nA) of
0.5-second duration was injected at a frequency of 1 Hz for 2 to 3
minutes using the circuitry of an amplifier (707, WPI) and a voltage
pulse generator (SEN7203, Nihon Kohden). For induction of the
hypoxic condition, cardiomyocytes were treated for 5 hours with
0.2 mmol/L CoCl2,19 because microinjection methods are not suit-
able for gas-tight chamber experiments with N2 substitution. Cells
were treated either with ACh (0.5 mmol/L) alone or with both ACh
and atropine (0.1 mmol/L) before chemical hypoxia. Dye injection
was performed at room temperature (24°C to 26°C).
Statistical Analysis
Time of onset of the first run of VT was analyzed by the Kaplan-
Meier method, and comparisons were made with the Mantel-
Haenszel log-rank test. A nonparametric test for comparison of
treatments with a control was performed by a Mann-Whitney U test
with Bonferroni adjustment. Differences were considered significant
at P0.05. Values are expressed as meanSD.
Results
In Vivo Arrhythmia Study
Effects of VS on Acute Ischemia-Induced VT
Figure 1 illustrates an example of the VT observed after LCA
ligation with sham stimulation in the MI-SS group. As
demonstrated in this case, VT followed by ventricular fibril-
lation was often detected after LCA ligation without VS.
Figure 2 shows the time of onset and the incidence of the first
spontaneous VT after LCA ligation. Eight of 12 rats in the
MI-SS group experienced VT; on the other hand, only 1 of 11
in the MI-VS group developed VT during the 30-minute LCA
ligation (67% versus 9%, P0.005). VS achieved an 87%
reduction in the relative incidence ratio of VT. In all cases,
the first runs of VT were observed within 15 minutes after
LCA ligation. Atropine administration abolished the anti-VT
effects of VS; 4 of 6 rats developed VT (Figure 2). No VT
was detected in either the SO-SS or SO-VS groups.
To exclude vagally induced bradycardiac effects on the
incidence of VT, a group of 9 rats were subjected to
preconditioning by VS (pcVS-MI group; see Methods). There
was no significant difference in heart rate between the MI-SS
and pcVS-MI groups immediately before and after LCA
ligation (Table). Nevertheless, only 2 of 9 rats in the
pcVS-MI group developed VT (22%, P0.04 versus the
MI-SS group).
Risk Area Assessment and Hemodynamic Parameters
There was no significant difference in risk area between the
MI-SS and MI-VS groups (556% versus 593%). The
differences in heart rate between groups with or without VS
reached 50 bpm, and after 30-minute ischemia, only the
MI-VS group had a significantly lower arterial pressure than
the SO-SS group (Table).
Excised Heart Study
Effects of VS on Cx43 Expression
The polyclonal anti-Cx43 antibody in the present study
showed closely spaced bands migrating between 43 and 46
kDa and a faint band migrating at 41 kDa. Previous reports20
demonstrated that the higher- and lower-molecular-weight
bands represent phosphorylated and nonphosphorylated iso-
forms of Cx43, respectively. Figure 3A shows a representa-
tive immunoblot prepared with anti-Cx43 antibody. The
phosphorylated isoform of Cx43 (bands with 43 kDa) in the
MI-VS group was preserved compared with that in the MI-SS
group. Quantitative densitometric analysis revealed the level
of the phosphorylated isoform of Cx43 in the MI-VS group
was maintained at 7918% of that in the SO-SS group; on
the other hand, the level of phosphorylated Cx43 in the
MI-SS group was reduced significantly to 3720% of that in
the SO-SS group (Figure 3B). The phosphorylated Cx43 in
the SO-VS group was increased significantly to 1208% of
that in the SO-SS group. Atropine inhibited the preserving
effects of VS on Cx43 in the MI-VS-Atr group (4712%). In
addition, protein analysis also confirmed that the phosphor-
ylated Cx43 in the pcVS -MI group was at almost the same
level as in the SO-SS group (9720%).
Effects of VS on Cx43 Localization
To investigate the distribution of Cx43 during acute ischemia
with or without VS, we performed confocal image analysis of
left ventricular tissues stained with anti-Cx43 antibody. As
shown in Figure 4A, localization of immunoreactive signals
Figure 1. Example of run of VT induced by LCA ligation in rat
treated with sham stimulation. In this case, ventricular fibrillation
was initiated after ventricular tachycardia. SAP indicates sys-
temic arterial pressure.
Figure 2. Incidence and onset of first VT after LCA ligation.
Myocardial ischemia rats treated with sham stimulation (MI-SS,
, n12) and with vagal stimulation (MI-VS, , n11). VS signifi-
cantly (P0.005 vs MI-SS group) decreased incidence of ische-
mia-induced VT. In contrast, atropine administration blocked
antiarrhythmogenic effect by VS during acute MI (MI-VS-Atr,
‘, n6). Preconditioning by VS significantly (P0.04 vs MI-SS
group) decreased incidence of ischemia-induced VT (pcVS-MI,
, n9).
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in the SO-SS group was restricted to intercellular junctions,
consistent with the gap junctions and intercalated disks. In
contrast, the Cx43 signal was reduced dramatically in the MI-SS
group (Figure 4B); however, the Cx43 signal in the MI-VS
group was almost comparable to the level in the SO-SS group
(Figure 4C). These observations indicate that the loss of phos-
phorylated Cx43 during acute ischemia was prevented by VS.
Primary Culture Study
Effects of Hypoxia and ACh on Cx43 Expression
To examine the muscarinic effect on hypoxia-induced loss of
phosphorylated Cx43, immunoblot analysis was performed in
primary cultured cardiomyocytes. Under normoxic condi-
tions, addition of ACh for 30 minutes significantly increased
the phosphorylated isoform of Cx43 compared with the
control group (Figure 5). Although hypoxia for 30 minutes
decreased phosphorylated Cx43, ACh treatment prevented
this hypoxia-induced loss of Cx43. Atropine inhibited the
preserving effects of ACh. Thus, these results indicate that
ACh preserved phosphorylated Cx43 through a muscarinic
receptor during 30-minute hypoxia.
Effects of Hypoxia and ACh on Intercellular Coupling
and Beating Rate
To assess whether the induction of phosphorylated Cx43 by
ACh results in a functional effect on cell-to-cell communica-
tion, LY dye transfer analysis was performed in primary
cultured cardiomyocytes. As shown in Figure 6A, under
normoxic conditions, LY injected into a cardiomyocyte
diffused into other cardiomyocytes around the injected cell.
In contrast, LY injected into a cardiomyocyte under chemical
hypoxic conditions was confined to the injected cell, and no
dye coupling with other cardiomyocytes was observed (Fig-
ure 6B); on the other hand, ACh administration preserved
cell-to-cell communication (Figure 6C). Atropine treatment
inhibited the preventive effect of ACh on hypoxia-induced
uncoupling (Figure 6D). Under normoxic conditions, ACh
treatment remarkably induced dye coupling between cardio-
myocytes (Figure 6E).
Under normoxic conditions, the rate of spontaneous beat-
ing was 6213 bpm (n5 experiments), and ACh did not
slow the beating rate. Chemical hypoxia with CoCl2 stopped
the beating; however, even under hypoxic conditions, ACh
preserved spontaneous beating. In the presence of atropine,
ACh failed to prevent the hypoxia-induced cessation of
beating. The results of Cx43 immunoblotting under chemical
hypoxic conditions were identical to those under hypoxia
with 2% O2 (data not shown).
Discussion
In the present study, we investigated whether VS could
attenuate acute MI-induced arrhythmogenic properties via
modulation of a principal cardiac gap-junction protein, Cx43.
Our results provide novel evidence that VS effectively
Heart Rate and Mean Arterial Pressure Immediately Before and After 30-Minute
LCA Ligation
Heart Rate, bpm Mean Arterial Pressure, mm Hg
Group n Before After 30-Minute Ligation Before After 30-Minute Ligation
SO-SS 6 40424 41424 11814 11613
SO-VS 5 36210* 34815* 1069 966
MI-SS 12 39522 36543 1177 10210
MI-VS 11 35412* 35331* 10213 906*
MI-VS-Atr 6 40920 36248 1038 9415
pcVS-MI 9 39133 37236 10911 10310
VS was started at 1 minute before LCA ligation and continued for 30 minutes after LCA ligation.
pcVS was performed during 10 minutes without LCA ligation, and after a 5-minute stabilization period
for recovery of heart rate, rats were subjected to a 30-minute LCA ligation. Values are meanSD
immediately before and after 30-minute LCA ligation.
*P0.05 vs SO-SS group.
Figure 3. A, Representative immunoblots of homogenate of left
ventricles from SO-SS, SO-VS, MI-SS, MI-VS, MI-VS-Atr, and
pcVS-MI rats, probed with polyclonal Cx43 antibody. Arrows
indicate position of phosphorylated isoform of Cx43 (43 kDa)
and nonphosphorylated isoform of Cx43 (41 kDa) bands,
respectively. B, Quantitative densitometric analysis of phosphor-
ylated isoform of Cx43 in SO-SS, SO-VS, MI-SS, MI-VS, MI-VS-
Atr, and pcMI-VS groups. Data are expressed as meanSD.
a.u. indicates arbitrary units. n5 for each group. *P0.05.
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inhibits loss of the phosphorylated isoform of Cx43 during
acute MI. Although the precise mechanism by which VS
modulates the dephosphorylation of Cx43 remains unknown,
it is most likely that VS exerts its antiarrhythmogenic effects
on ischemic ventricular myocytes through the preserved
function of Cx43.
VS and Antiarrhythmogenic Properties
VS has already been reported to prevent ventricular fibrilla-
tion in dogs.14 In the present study, we hypothesized that VS
exerts its antiarrhythmogenic properties by maintaining elec-
trical coupling with ventricular cardiomyocytes as a result of
prevention of Cx43 dephosphorylation induced by acute MI.
However, because VS simultaneously evokes a bradycardiac
effect, the question remains whether the heart rate decelera-
tion caused by VS is a primary mechanism for antiarrhythmic
properties during MI. In a preliminary study, we confirmed
that short-term exposure of cultured cardiomyocytes to ACh
only before hypoxia prevented the hypoxia-induced loss of
phosphorylated Cx43 (unpublished observations, 2004).
Therefore, it is conceivable that ACh had a cardioprotective
effect independent of the heart rate–slowing mechanism
during hypoxia or ischemia. To further clarify such a precon-
ditioning effect in in vivo experiments, we examined whether
hearts preconditioned by VS were insusceptible to ischemia-
induced VT and whether pcVS prevented the ischemia-
induced loss of Cx43. As expected, we confirmed that pcVS
exerted its antiarrhythmogenic effects and sustained the level
of phosphorylated Cx43 during ischemia. These results sug-
gest that VS or ACh had a cardioprotective effect indepen-
dent of the heart rate–slowing mechanism.
It is well recognized that Cx43, which is the principal
component of ventricular gap-junction proteins, contributes
to intercellular communication and electrical coupling.
Beardslee et al21 showed that Cx43 underwent marked de-
phosphorylation during the process of electrical uncoupling
induced by ischemia. Genetically engineered Cx43-deficient
(Cx43/ or Cx43/) mice have been reported to be markedly
susceptible to ischemia-induced VT.12,13,22 In the present
study, VS drastically reduced the incidence of VT and
prevented the loss of phosphorylated Cx43 during acute MI.
Therefore, functional preservation of Cx43 by VS would play
an important role in antiarrhythmogenic properties during
acute MI.
The result that ACh administration ameliorated the hypox-
ia-induced loss of dye coupling in cardiomyocytes is consis-
tent with that of ACh-induced upregulation of phosphorylated
Cx43. Under normoxic conditions, ACh did not slow down
the spontaneous beating rate of cardiomyocytes. Hypoxia
stopped the beating and diminished the phosphorylated iso-
form of Cx43; however, even under hypoxic conditions, ACh
preserved the spontaneous beating and the phosphorylated
isoform of Cx43. Therefore, it is conceivable that ACh has a
cardioprotective effect independent of the beating rate.
Upregulation of Cx43 has been reported to accelerate
spontaneous beating in cultured cardiomyocytes.23 Moreover,
Figure 4. Representative confocal images of rat left ventricles
from SO-SS rats (A), MI-SS rats (B), and MI-VS rats (C). Positive
immunoreactive signals were concentrated in discrete spots at
sites of intercellular apposition (red).
Figure 5. Representative immunoblots of homogenates from
primary cultured rat cardiomyocytes probed with polyclonal
anti-Cx43 antibody. Hypoxic treatment for 30 minutes
decreased phosphorylated Cx43. ACh treatment prevented hyp-
oxia-induced loss of phosphorylated Cx43. Atr inhibited ACh
effect. Under normoxic conditions, ACh significantly increased
phosphorylated isoform of Cx43 compared with control group.
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cultured cardiomyocytes from genetically engineered Cx43-
deficient (Cx43/) mice demonstrated slow spontaneous
beating rates and were poorly synchronized with each other
compared with wild-type cultured cardiomyocytes.24 From
these findings and the present results, we speculate that ACh
exerts its antiarrhythmogenic properties on ischemic or hy-
poxic hearts by preserving Cx43 and that such a beneficial
effect is independent of its bradycardiac effect.
The spatial distribution of Cx43 can influence electrical
stability of the heart. A more recent study by Poelzing and
Rosenbaum11 has shown that the transmural derangement of
Cx43 expression can potentially be an arrhythmogenic sub-
strate in the canine model of pacing-induced heart failure.
Although we did not evaluate the transmural heterogeneity of
Cx43 expression in the present study, such an analysis would
be needed to clarify precise mechanisms for the antiarrhyth-
mogenic effects of VS.
How Does VS Modulate Phosphorylated Cx43?
Three potential mechanisms might be involved in the linkage
between VS and the sustained phosphorylated-protein level
of Cx43 during acute MI. First, VS may activate several
protein kinases and induce phosphorylation of Cx43 through
muscarinic receptors.25 Liu et al26 demonstrated that ACh
prevented ischemic injury in cultured cardiomyocytes by
activating protein kinase C, and the protective effect was
mediated through a nitric oxide–dependent pathway. Second,
VS can block the degradation pathway of Cx43 during acute
MI. It has been reported that Cx43 is a short-lived protein
with a half-life of only 1 to 3 hours in adult hearts20 and that
both lysosomal and proteasomal degradation play distinct
roles in the life cycle of Cx43.27 Our observations in the
present study suggest that VS may prevent the ischemia-
induced loss of Cx43 as a consequence of inhibition of its
degradation pathway. Third, VS is also postulated to suppress
excessive inflammation. Recently, Tracey and colleagues28,29
identified a novel molecular link between the vagus nerve
system and an antiinflammatory response to disease. They
suggest that VS exerts an antiinflammatory effect via the
nicotinic ACh receptor 7-subunit expressed in macrophages.
The release of tumor necrosis factor- from macrophages is
inhibited by nicotinic stimulation. In contrast, the present
results indicate that VS exerts its antiarrhythmogenic effects
via muscarinic cholinergic receptors.
Study Limitations
In the present study, we did not measure the myocardial
interstitial level of ACh at the ischemic region during VS.
Therefore, it is unclear whether the cardiac vagal efferent
fiber innervating the ischemic region can release its neuro-
transmitter in response to electrical stimulation. An in vivo
microdialysis technique has enabled monitoring of the local
concentration of neurotransmitters such as catecholamines,
amino acids, and ACh. In the cat heart, Kawada et al showed
that VS increased the myocardial interstitial ACh level even
in the ischemic region (e-mail, February 12, 2004). Although
their previous study30 showed that acute MI induced the
nerve-firing independent release of ACh from the vagal
terminal, the electrical stimulation of the vagal efferent
during acute MI produced the significant additive release of
ACh to the myocardial interstitial space. Such an additional
release of ACh in response to electrical stimulation during
acute MI would play an important role in Cx43 preservation
in the ischemic region.
Conclusion and Future Aspects
The present study demonstrates that VS exerts antiarrhyth-
mogenic effects during acute MI accompanied by prevention
of the loss of phosphorylated Cx43. The preserved function of
Cx43 may improve electrical instability during acute MI. In
view of the present results, we can provide an alternative
therapeutic strategy with a neural interface approach. We
have already developed the sympathetic interface approach
for the treatment of central baroreflex failure in rats.31 To
establish the therapeutic strategy shown here, further studies
are required.
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CLINICAL PERSPECTIVE
Increased cardiac vagal tone reduces ventricular arrhythmias during acute myocardial ischemia and has been linked to a
lower risk of sudden arrhythmic death. Although the benefit of bradycardia associated with vagal tone is well appreciated,
this may not be the only benefit. Cardiomyocytes are electrically coupled to one another through gap junctions. This
coupling is critical to maintenance of cardiac electrical stability. Uncoupling occurs during ischemia and promotes
heterogeneity of repolarization and slowing of conduction, with proarrhythmic effects. In the present study, short-term
vagal stimulation (VS) was applied before or during acute ischemia in rats. VS protected against ventricular arrhythmias.
Furthermore, VS preserved a phosphorylated form of connexin 43 (Cx43), a major subtype of gap-junction proteins in
ventricles. In vitro studies of rat primary-cultured cardiomyocytes showed that ACh, a vagal efferent neurotransmitter,
effectively prevented hypoxia-induced loss of phosphorylated Cx43 proteins and maintained cell-to-cell communication.
Antiarrhythmic properties of VS and ACh were mediated via muscarinic receptors but were independent of heart rate
deceleration. That cellular coupling can be improved through neural stimulation may lead to novel therapeutic strategies
for preventing ventricular fibrillation during ischemia.
170 Circulation July 12, 2005
 at KOCHI UNIVERSITY on January 11, 2010 circ.ahajournals.orgDownloaded from 
